期刊文献+

荷乳腺癌小鼠c-myc mRNA反义寡核苷酸显像研究 被引量:1

Technetium-99m Labeled Antisense Oligonucleotides-Molecular Imaging in Breast Tumor Mice
下载PDF
导出
摘要 目的建立99mTc标记寡核苷酸的方法并用于荷乳腺癌小鼠反义寡核苷酸显像研究。方法利用双功能螯合剂N-羟基琥珀酰亚胺-巯乙苷肽(S-Acetyl-NHS-MAG3)对一段15碱基c-mycmRNA反义寡核苷酸片段进行99mTc标记;对荷乳腺癌昆明种小鼠进行标记反义寡核苷酸生物学分布与显像研究。结果生物学分布结果表明,相对于正义核酸而言,反义核酸在肿瘤组织中的摄取明显增高(P<0.05)。在反义寡核苷酸显像组,肿瘤组织显像剂摄取活跃,肿瘤/肌肉比值最高可达5.5。在正义寡核苷酸显像组及阻断组,肿瘤组织均未出现明显的显像剂浓聚。结论99mTc标记反义寡核苷酸有望成为一种新的显像剂,在分子水平上用于恶性肿瘤的早期、特异和无创性诊断。 Objective To establish the methods for Technetium-99m (99mTc) labeled antisense oligonucleotides used for antisense oligonucleotides imaging in breast tumor mice. Methods The 15-mer oligonucleotide sequence was synthesized, aminolinked (sense and antisense phosphodiester) and conjugated with S-Acetyl-NHS-MAG3 by a N-hydroxy-succinimide derivative. The purified MAG3-DNA was radiolabeled with ^99mTc by transchelation from sodium tartrate and free ^99mTc was separated by gel filtration. The radiolabeled antisense and sense probes were injected intravenously in breast tumor-bearing Kunming mice (1 × 10^6 cells, 6 days after inoculation). Biodistribution was studied and the mice were imaged. Results Essentially complete conjugation was achieved by reverse-phase Sep-Pak C18 chromatography analysis. The MAG3-DNA was labeled with ^99mTc at room temperature and neutral pH, with a mean labeling efficiency of 80.11% (s. d=2.96%, n=4). After labeling, the stability of the DNA in saline was retained as determined by reverse-phase Sep-Pak C18 chromatography analysis. Biodistribution studies revealed higher accumulation of antisense probes in tumor tissue than that of sense probes. In the antisense group, the tumor was clearly imaged since 30 min and the highest tumor to muscle ratio of 5.5 was obtained at 4 h post-injection. Positive imaging was not obtained in control group (in which non-conjugated, non-labeled antisense oligonucleotede was administered 2 h before radiolabeled antisense probes were injected) and sense group. Conclusion The ^99mTc labeled antisense probe may provide a sensible and specific tool for noninvasive imaging of e-myc oncogene mRNA for a variety of malignant tumors at an earlier stage.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期372-376,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No30070310)
关键词 反义寡聚核苷酸 肿瘤 放射性核素显像 ^99m锝 放射性标记 硫乙琥珀酰亚胺-硫乙甘肽 oligonucleotides, antisense, tumor imaging Technetium-99m, radiolabeling S-Acetyl-NHS-MAG3
  • 相关文献

参考文献12

  • 1TAVITIAN B. In vivo imaging with oligonucleotides for diagnosis and drug development[J]. Gut, 2003,52 (Suppl 4): iv40-47. 被引量:1
  • 2GREEN D W, ROH H, PIPPIN J, et al. Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease[J]. J Am Coll Surg, 2000, 191(1) : 93-105. 被引量:1
  • 3KNOEPFLER P S. Myc goes global: new tricks for an old oncogene[J]. Cancer Res, 2007, 67(11): 5061-5063. 被引量:1
  • 4BAENA E, ORTIZ M, MARTINEZA C, et al. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin( - ) Sca-1 (+) c-Kit( - ) cell generation through p21 [J]. Exp Hematol, 2007, 35(9): 1333-1343. 被引量:1
  • 5DOMINGUEZ-SOLA D, YING C Y, GRANDORI C, et al. Non transcriptional control of DNA replication by c-Myc[J]. Nature, 2007,448(7152) :445-451. 被引量:1
  • 6AMATO R J. Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy [J]. Clin Genitourin Cancer, 2007,5(7) :422-426. 被引量:1
  • 7SAHU N K, SHILAKARI G, NAYAK A, et al. Antisense technology: a selective tool for gene expression regulation and gene targeting[J]. Curr Pharm Biotechnol, 2007,8(5): 291- 304. 被引量:1
  • 8DEWANJEE M K, GHAFOURIPOUR A K, KAPADVANJWALA M, et al. Noninvasive imaging of c myc oncogene messenger RNA with Indium-111-antisense probes in a mammary-bearingmousemodel[J]. J Nucl Med, 1994, 35(6):1054-1063. 被引量:1
  • 9秦光明.肿瘤核素反义显像技术的研究现状与展望[J].国外医学(放射医学核医学分册),2001,25(5):213-216. 被引量:3
  • 10SCHERR M, ROSSI J J, SCZAKIEL G, et al. RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts[J]. Nucleic Acids Res, 2000, 28(13), 2455-2461. 被引量:1

二级参考文献17

  • 1Hnatowich DJ. Antisense and nuclear medicine[J]. J Nucl Med, 1999,40:693-703. 被引量:1
  • 2De Oliveira MC, Boutet V, Fattal E, et al. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice[J]. Life Sci,2000,67(13) :1625-1637. 被引量:1
  • 3David DFM, Wei Ai-qun. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes[J]. Leuk Res, 1996,20: 925-930. 被引量:1
  • 4Sczakiel G. Theoretical and experimental approaches to design effective antisense oligonucleotides [J].Front Biosci, 2000,5 :D194-D201. 被引量:1
  • 5Larsen HJ, Bentin T, Nielsen PE. Antisense properties of peptide nucleic acid[J]. Biochim Biophys Acta,1999,1489(1) :159-166. 被引量:1
  • 6Lubrich B, Calker D, Peschka SR. Inhibition of inositol uptake in astrocytes by antisense oligonucleotides delivered by pH-sensitive liposomes [J ]. Eur J Biochem, 2000,267 (8): 2432-2438. 被引量:1
  • 7Hu RH, Chu SH. Suppression of tumor necrosis factor secretion from white blood cells by synthetic antisense phosphorothioate oligodeoxynucleotides[J]. Int J Immunopharmacol, 2000,22(6): 445-452. 被引量:1
  • 8Dewanjee MK, Abdol KG, Kapadvanjwala M, et al.Noninvasive imaging of c-myc oncogene messenger RNA with Indium-111-antisense probes in a mammary tumor-bearing mouse model[J]. J Nucl Med, 1994,35:1054-1063. 被引量:1
  • 9Dewanjee MK, Ghafouripour AK, Kapadvanjwala M,et al. Noninvasive imaging of c-erbB2 oncogen mRNA of breast tumor in mouse model with In-111 labeled antisens oligonucleotide [J ]. J Nucl Med, 1994, 35:65. 被引量:1
  • 10Urbain JC, Shore SK, Vekemans MC, et al. Scintigraphic imaging of oncogens with antisense probes:does it make sense? [J]. Eur J Nucl Med,1995, 22:499-504. 被引量:1

共引文献2

同被引文献10

  • 1彭涛,王林.从大麻中发现新药[J].国外医学(药学分册),2006,33(2):154-155. 被引量:3
  • 2Oesch S,Gertsch J.Cannabinoid receptor ligands as potential anticancer agents-high hopes for new therapies[J].J Pharm Pharmacol,2009,61(7):839-853. 被引量:1
  • 3Bifulco M,Laezza C,Gazzerro P,et al.Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion(review)[J].Oncol Rep,2007,17(4):813-816. 被引量:1
  • 4Freimuth N,Ramer R,Hinz B.Antitumorigenic effects of cannabinoids beyond apoptosis[J].J Pharmacol Exp Ther,2010,332(2):336-344. 被引量:1
  • 5Casanova M L,Blazquez C,Martinez-palacio J,et al.Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors[J].J Clin Invest,2003,111(1):43-50. 被引量:1
  • 6Osei-hyiaman D,Depetrillo M,Pacher P,et al.Endocannabi-noid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity[J].J Clin Invest,2005,115(5):1130-1133. 被引量:1
  • 7Xu X,Liu Y,Huang S F,et al.Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma[J].Cancer Genet Cytogenet,2006,171(1):31-38. 被引量:1
  • 8Di Marzo V,De Petrocellis L.Plant,synthetic,and endogenous cannabinoids in medicine[J].Annu Rev Med,2006,57(5):553-574. 被引量:1
  • 9Sarfaraz S,Adhami V M,Syed D N,et al.Cannabinoids for cancer treatment:progress and promise[J].Cancer Res,2008,68(2):339-342. 被引量:1
  • 10Liao D J,Thakur A,Wu J,et al.Perspectives on c-Myc,Cyclin D1,and their interaction in cancer formation,progression,and response to chemotherapy[J].Crit Rev Oncog,2007,13(2):93-158. 被引量:1

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部